Sandoz Group (OTCMKTS:SDZNY) Sets New 1-Year High – Here’s What Happened

Posted by Alanna Baker on Feb 18th, 2026

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY – Get Free Report) shares reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $87.57 and last traded at $86.78, with a volume of 270394 shares traded. The stock had previously closed at $85.73.

Analysts Set New Price Targets

Separately, Jefferies Financial Group raised Sandoz Group from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 12th. Two equities research analysts have rated the stock with a Strong Buy rating, According to data from MarketBeat, the stock currently has an average rating of “Strong Buy”.

Check Out Our Latest Stock Report on Sandoz Group

Sandoz Group Stock Performance

The company has a current ratio of 1.29, a quick ratio of 0.82 and a debt-to-equity ratio of 0.62. The business has a 50-day simple moving average of $77.05 and a two-hundred day simple moving average of $68.02.

Sandoz Group Company Profile

(Get Free Report)

Sandoz Group (OTCMKTS:SDZNY) is a multinational pharmaceutical company focused on the development, manufacturing and commercialization of generic medicines and biosimilars. The company supplies off-patent small-molecule drugs as well as biologic alternatives intended to offer lower-cost therapeutic options across a range of clinical areas. Sandoz emphasizes access and affordability, positioning its portfolio to serve hospitals, pharmacies and health systems looking to expand patient access to essential therapies.

The company’s product offerings span conventional generics, complex and specialty generics, and a growing pipeline of biosimilar medicines.